4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-053380
10% owner sold 105,894 shares at an average $29.29 ($3,101,344)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| UBS Oncology Impact Fund L.P. 10% owner | 2021-08-23 | Sale | −53,359 | $29.11 | $1,553,280 | 7,858,018 | D |
| UBS Oncology Impact Fund L.P. 10% owner | 2021-08-24 | Sale | −50,822 | $29.48 | $1,498,233 | 7,807,196 | D |
| UBS Oncology Impact Fund L.P. 10% owner | 2021-08-25 | Sale | −1,713 | $29.09 | $49,831 | 7,805,483 | D |
| Open-market sales · 105,894 sh · avg $29.29 · $3,101,344 | |||||||
Loading xslF345X03/doc4.xml…